Verici Dx plc (AIM:VRCI)
London · Delayed Price · Currency is GBP · Price in GBX 0.3500
-0.0250 (-6.67%)
Jul 7, 2026, 2:49 PM GMT
Verici Dx Market Cap
Verici Dx has a market cap or net worth of 5.68 million as of July 7, 2026. Its market cap has increased by 107.99% in one year.
Market Cap
5.68M
Enterprise Value
3.34M
Revenue
2.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.35
Market Cap Chart
Since November 3, 2020, Verici Dx's market cap has decreased from 51.74M to 5.68M, a decrease of -89.03%. That is a compound annual growth rate of -32.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 5.68M | -48.28% |
| Dec 31, 2025 | 10.97M | 16.74% |
| Dec 31, 2024 | 9.40M | -43.40% |
| Dec 29, 2023 | 16.61M | -22.00% |
| Dec 30, 2022 | 21.29M | -71.66% |
| Dec 31, 2021 | 75.13M | -9.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 224.21B |
| GSK plc | 80.29B |
| Haleon | 32.12B |
| Smith & Nephew | 9.56B |
| GENinCode | 6.78M |
| OptiBiotix Health | 6.66M |
| Proteome Sciences | 5.70M |
| CRISM Therapeutics | 5.69M |